-
Noncompliance
informed decision on the part of the patient not to adhere to or follow a therapeutic plan or suggestion
-
Outcome criteria
Descriptions of specific patient behaviors or responses that demonstrate meeting of or achievement of goals related to each nursing diagnosis
-
Nursing process
organizational framework for the practice of nursing
-
compliance
Implementation or fulfillment of a prescriber's or caregiver's prescribed course of treatment or therapeutic plan by a patient
-
Goals
Statements that are time specific and describe generally what is to be accomplished
-
Medication error
Any preventable adverse drug event involving inappropriate medication use by a patient or health care professional
-
Objective Data
information available through the senses, such as what is seen, felt, heard, and smelled
-
subjective data
all spoken info shared by the patient
-
Part 1 ND
"dificient knowledge"
This is the statement of the human response of the patient to illness, injury, medications, or significant change
-
Part 2 ND
"Related to lack of experience with medication regimen and second-grade reading level as an adult"
This identifies factors related to a response
-
Part 3 ND
"As evidenced by inability to perform a return demonstration and inability to state adverse effects to report to the prescriber
lists clues, cues, evidence, and/or data that support the nurse's claim
-
Assessment
data collected , reviewed and analyzed; diagnosis formulated .
-
NANDA
North American Nursing Diagnosis Association
-
NANDA Does
visibility of nursing's contribution to patient care, develops, refines, and classifies information ,supports for the improvement of quality nursing care through evidence-based practice, provides a working organization for the development of evidence-based nursing diagnoses
-
Charting Donts
- -record staffing problems
- record peers conflicts
- -mention incident report in charting
- -say “by mistake,” “by accident,” “accidentally,” “unintentional,” or “miscalculated
- -anything other than facts
- chart casual convo with peers
- -use negative languaga
-
Prescriber
health care professional licensed to prescribe medications
-
additive effects
effects with combination of two or more drugs with similar actions is equivalent to the sum of the individual effects
-
Adverse drug event
undesirable occurrence related to administering or failing to administer a med
-
adverse drug reaction
unexpected, unintended, undesired, or excessive response to a medication
-
adverse effects
any undesirable effects that are a direct response to one or more drugs
-
Agonist
binds to and stimulates the activity of one or more receptors in the body
-
allergic reaction
immunologic hypersensitivity reaction resulting from the unusual sensitivity to a medication
-
antagonist (inhibitor)
A drug that binds to and inhibits the activity of one or more receptors in the body
-
Antagonistic effects
the effect of a combination of two or more drugs is less than the sum of the individual
-
Bioavailability
measure of the extent of drug absorption for a given drug and route (0 to 100%)
-
Biotransformation (metabolism)
One or more biochemical reactions involving a parent drug (LIVER)
-
Blood brain barrier
barrier system that restricts the passage of various chemicals and microscopic entities between blood and CNS; allows O2 to pass
-
Chemical name
name that describes chemical composition and molecuklar structure
-
Contraindiction
condtion that rnders a particular form of treatment(against it)
-
Cytochrome P-450
large class of enzymes that play a significant role in drug metabolism
-
dependence
state in which there is a compulsive or chronic need of drugs
-
Dissolution
solid drugs disentigrate in gi tract, soluble then absorbed in circulation
-
Drug
chemical that affects the physiologic processes of a living organism
-
drug actions
cellular processes involved in the interaction between a drug and body cells
-
Drug effects
physiologic reactions of the body to a drug
-
Drug-induced teratogenesis
development of congenital anomalies or defects in the developing fetus caused by the toxic effects of drugs
-
Drug interaction
Alteration in the pharmacologic activity of a given drug caused by the presence of one or more additional drugs
-
Duration of action
length of time the concentration of a drug in the blood or tissues is sufficient to elicit a response
-
Enzymes
Protein molecules that catalyze one or more of a variety of biochemical reactions
-
First Pass effect
The initial metabolism in the liver of a drug absorbed from the gastrointestinal tract
-
Generic name (non proprietary)
name given to a drug by the United States Adopted Names Council
-
Half Life
time required for half of an administered dose of drug to be eliminated by the body
-
Idiosyncratic reaction
abnormal and unexpected response to a medication ; peculiar to an individual patient
-
Incompatibility
two parenteral drugs or solutions to undergo a reaction when mixed
-
Intraarticular
Within a joint
-
Intrathecal (theca in spinal cord )
within a sheath
-
Medication use process
prescribing, dispensing, and administering of medications and monitor effects
-
Metabolite
A chemical form of a drug that is the product of one or more biochemical (metabolic) reactions involving the parent drug ; active= pharmacologic activity , inactive = no pharmacologic activity
-
onset of action
Time required for drug to elicit response
-
parent drug
chemical form of a drug that is administered before it is metabolized by the body's biochem rxn
-
peak effect
time required for a drug to reach its maximum therapeutic response
"HIGHEST BLOOD LEVEL "
-
peak level
maximum concentration of a drug in the body after administration (measured in blood sample)
-
Pharmaceutics
- science of preparing and dispensing drugs
- * disentigrates then dissolution
-
pharmacodynamics
study of the biochemical and physiologic interactions of drugs at their sites of activity
-
pharmacoginetics
study of the influence of genetic factors on drug response
-
pharmacognosy
study of drugs that are obtained from natural plant and animal sources
-
pharmacokinetics
rate of drug distribution among various body compartments after a drug has entered the body (absorption distribution metabolism excretion)
-
Drug absorption
liquuids faster then enteric caps slower
-
Pharmacology
study or science of drugs
-
pharmacotherapeutics
txt of pathologic condition thru drugs
-
prodrug
an inactive drug dosage form
-
Receptor
molecular structure within or on the outer surface of a cell
-
steady state (equal)
physiologic state in which the amount of drug removed via elimination is equal to the amount of drug absorbed
-
Substrates
Substances (e.g., drugs or natural biochemicals in the body) on which an enzyme acts
-
Synergistic effects
effect of a combination of two or more drugs with similar actions is greater than the sum of the individual effects
-
Therapeutic drug monitoring
measuring drug peak and trough levels, level of drug exposure
-
therapeutic effect
desired or intended effect of a particular medication
***A drug cannot make a cell or tissue perform a function it was not designed to perform***
-
therapeutic index
ratio between the toxic and therapeutic concentrations of a drug
-
tolerance
Reduced response to a drug after prolonged use
-
Toxic
quality of being poisonous
-
toxicity
condition of producing adverse bodily effects due to poisonous qualities
-
toxicology
study of poisons, including toxic drug effects, and applicable treatments
-
Trade name
commercial name given to a drug product by its manufacturer
-
trough level
lowest concentration of drug reached in the body after it falls from its peak level
"LOWEST BLOOD LEVEL"
-
Pharmaceutical phase 1
disentigration and dissolution
-
Pharmaceutical phase 2
absorption ,distribution and metabolism , excretion
-
pharmaceutical phase 3
drug receptor interaction
-
Three basic areas of pharmacology
pharmaceutics, pharmacokinetics, and pharmacodynamics
-
Routes
Enternal, parenternal, topical
-
Enternal route
Tablets, capsules, pills, timed-release capsules, timed-release tablets, elixirs, suspensions, syrups, emulsions, solutions, lozenges or troches, rectal suppositories, sublingual or buccal tablets
**absorbed rapidly into the bloodstream
-
Parenternal Route
Injectable forms, solutions, suspensions, emulsions, powders for reconstitution
*absorbed over a period of several hours; IV rapid onset
-
Topical Route
Aerosols, ointments, creams, pastes, powders, solutions, foams, gels, transdermal patches, inhalers, rectal and vaginal suppositories
-
Absorption
movement of a drug from site of administration into the bloodstream for distribution to the tissues
-
First pass routes
Hepatic arterial , Oral, Portal venous and Rectal
Non -first pass (all intra-drugs, inhaled, sub drugs )
-
enzyme IA2
acetaminophen, caffeine, theophylline, warfarin
-
Enzyme 2C9
ibuprofen, phenytoin
-
enzyme 2C19
diazepam, naproxen, omeprazole, propranolol
-
2D9
codeine, fluoxetine, hydrocodone, metoprolol, oxycodone
-
2E1
acetaminophen, ethanol
-
3A4
acetaminophen, amiodarone, cyclosporine, diltiazem, ethinyl estradiol, indinavir, lidocaine
-
active transport
active energy-required movment
-
Diffusion
passive movement of a substance; from high to low concentration
-
elderly
person over 65:
- *13% of the total population
- *recieve 30% of all prescription med
- *40% of all OTC drugs
-
neonate
younger than 1 month of age
-
Nomogram
tool for estimating drug dosages using various body measurements
-
pediatric
12 yrs old or younger
-
Polypharmacy
use of many different drugs concurrently in treating a patient
|
|